BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1583658)

  • 1. Principles and practicalities of carrier screening: attitudes of recent parents.
    Green JM
    J Med Genet; 1992 May; 29(5):313-9. PubMed ID: 1583658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis carrier population screening in the primary care setting.
    Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
    Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis: community knowledge and attitudes towards carrier screening and prenatal diagnosis.
    Decruyenaere M; Evers-Kiebooms G; Denayer L; Van den Berghe H
    Clin Genet; 1992 Apr; 41(4):189-96. PubMed ID: 1576756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF).
    Henneman L; Bramsen I; Van Os TA; Reuling IE; Heyerman HG; van der Laag J; van der Ploeg HM; ten Kate LP
    Prenat Diagn; 2001 Jan; 21(1):1-9. PubMed ID: 11180232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes toward genetic testing of Amish, Mennonite, and Hutterite families with cystic fibrosis.
    Miller SR; Schwartz RH
    Am J Public Health; 1992 Feb; 82(2):236-42. PubMed ID: 1739154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes of cystic fibrosis patients and parents toward carrier screening and related reproductive issues.
    Janssens S; Chokoshvilli D; Binst C; Mahieu I; Henneman L; De Paepe A; Borry P
    Eur J Hum Genet; 2016 Apr; 24(4):506-12. PubMed ID: 26220700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal screening for cystic fibrosis carriers: does the method of testing affect the longer-term understanding and reproductive behaviour of women?
    Mennie ME; Axworthy D; Liston WA; Brock DJ
    Prenat Diagn; 1997 Sep; 17(9):853-60. PubMed ID: 9316130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes towards prenatal diagnosis and carrier screening for cystic fibrosis among the parents of patients in a paediatric cystic fibrosis clinic.
    Watson EK; Marchant J; Bush A; Williamson B
    J Med Genet; 1992 Jul; 29(7):490-1. PubMed ID: 1640429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis heterozygote screening in 5,161 pregnant women.
    Witt DR; Schaefer C; Hallam P; Wi S; Blumberg B; Fishbach A; Holtzman J; Kornfeld S; Lee R; Nemzer L; Palmer R
    Am J Hum Genet; 1996 Apr; 58(4):823-35. PubMed ID: 8644747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn bloodspot screening for cystic fibrosis: What do antenatal and postnatal women know about cystic fibrosis?
    Fitzgerald C; Linnane B; Heery E; Conneally N; George S; Fitzpatrick P
    J Cyst Fibros; 2016 Jul; 15(4):436-42. PubMed ID: 26708264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cascade carrier testing after a child is diagnosed with cystic fibrosis through newborn screening: investigating why most relatives do not have testing.
    McClaren BJ; Aitken M; Massie J; Amor D; Ukoumunne OC; Metcalfe SA
    Genet Med; 2013 Jul; 15(7):533-40. PubMed ID: 23348769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis carrier screening in a high-risk population. Participation based on a traditional recruitment process.
    Surh LC; Cappelli M; MacDonald NE; Mettler G; Dales RE
    Arch Pediatr Adolesc Med; 1994 Jun; 148(6):632-7. PubMed ID: 8193692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier screening for cystic fibrosis: a perinatal perspective.
    Demsey SA
    J Perinat Neonatal Nurs; 1999 Sep; 13(2):14-26. PubMed ID: 10818851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research.
    Ioannou L; McClaren BJ; Massie J; Lewis S; Metcalfe SA; Forrest L; Delatycki MB
    Genet Med; 2014 Mar; 16(3):207-16. PubMed ID: 24030436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population screening for cystic fibrosis: knowledge and emotional consequences 18 months later.
    Gordon C; Walpole I; Zubrick SR; Bower C
    Am J Med Genet A; 2003 Jul; 120A(2):199-208. PubMed ID: 12833400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To know or not to know, disclosure of a newborn carrier screening test result for cystic fibrosis.
    Vernooij-van Langen AM; Reijntjens S; van der Pal SM; Loeber JG; Dompeling E; Dankert-Roelse JE
    Eur J Med Genet; 2013 Apr; 56(4):192-6. PubMed ID: 23352994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing carrier screening for cystic fibrosis outside the clinic: ethical analysis in the light of the personalist view.
    Di Pietro ML; Teleman AA; Gonzalez-Melado FJ; Zace D; Di Raimo FR; Lucidi V; Refolo P
    Clin Ter; 2018; 169(2):e71-e76. PubMed ID: 29595869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis gene analysis: recent diagnostic applications.
    Fujimura FK
    Clin Biochem; 1991 Aug; 24(4):353-61. PubMed ID: 1959227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis carrier screening in Veneto (Italy): an ethical analysis.
    Bruni T; Mameli M; Pravettoni G; Boniolo G
    Med Health Care Philos; 2012 Aug; 15(3):321-8. PubMed ID: 21863402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.